Technology Platform
From Blood Samples to Meaningful Health Insights
How the Technology Works | Transforming Biological Responses into Actionable Insights
Turning Test Results into a Better Understanding of the Body
At Excelsior Bio-System, testing is more than generating a single result. Through a comprehensive testing process, biological responses to environmental factors and dietary exposures are transformed into meaningful information, allowing health-related patterns that may otherwise go unnoticed to be presented in a clear and understandable way.
The Value of Testing Lies in Interpretation and Application
The true value of testing is not merely the data itself, but how effectively that information can be interpreted and applied. Through systematic testing and analysis, our solutions help users better understand their biological responses and provide valuable reference points for health management and lifestyle decisions.
Core Technologies | The Foundation of Our Testing Platform
Excelsior Bio-System has long been dedicated to research and development in immunological testing, in vitro diagnostics, and related technologies. From allergen protein preparation and assay development to protein microarray and rapid testing technologies, we have established a comprehensive technological foundation that supports our testing platform.
To address diverse application needs and testing scenarios, we have developed multiple technology formats and product solutions, including laboratory-based testing and point-of-care rapid testing. This enables our technologies to be integrated into a wide range of healthcare, diagnostic, and wellness settings.
Testing Mechanisms Based on Immune Responses
Our tests are based on immunological principles. Specific antigen-antibody reactions enable responses to different allergens to be effectively identified and quantified.
An Integrated, Multi-Technology Testing Platform
Excelsior Bio-System integrates protein microarray, immunoassay, and multiple testing technologies, enabling simultaneous analysis of multiple allergens on a single platform and establishing comprehensive testing capabilities.
Technology Workflow | How Test Results Are Generated
Sample Processing: The Starting Point of Testing
Testing begins with sample collection, followed by standardized processing to ensure the reliability of subsequent analysis.
Antibody Reactions and Signal Generation
Antibodies in the sample react with allergen proteins on the testing platform, and labeling technologies convert these reactions into detectable signals.
Data Conversion and Report Generation
Signal analysis and data conversion ultimately produce a readable test report, translating complex biological reactions into understandable information.
Technical Advantages | Key Elements Supporting Reliable Testing
Multiple Tests from a Small Sample Volume
Testing begins with sample collection, followed by standardized processing to ensure the reliability of subsequent analysis.
Multi-Analyte Analysis on a Single Platform
Multiple allergens can be tested simultaneously on a single platform, improving testing efficiency and providing more comprehensive results.
Technology Framework | The Technologies Behind Our Testing Capabilities
Raw Material Preparation Technology
Includes the extraction and purification of allergen proteins, which serve as the foundational materials for the testing platform and influence the stability and accuracy of test results.
READ MORE →Protein Chip Technology Platform
Multiple allergen proteins are arranged in a microarray format for simultaneous multi-analyte testing, forming the core technology of allergy testing.
READ MORE →Enzyme-Linked Immunosorbent Assay (ELISA)
Testing is performed using enzyme immunoassay, a well-established and reliable immunodiagnostic method.
READ MORE →Rapid Test Reagents
Lateral flow immunochromatography provides a rapid and convenient testing approach for use across diverse settings.
READ MORE →FAQ
Answers to common technical questions to help explain different testing methods and their distinctions.
READ MORE →
